The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal cell carcinoma patients after progression on first-line therapies…
INDORE, India, Oct. 9, 2025 /PRNewswire/ -- At Apollo Rajshree Hospitals, a 36-year-old man with severe heart failure has been successfully…
NEW DELHI, Oct. 9, 2025 /PRNewswire/ -- MSN Laboratories, a leading global Indian pharmaceutical company, today announced that it is…
MUMBAI, India, Oct. 10, 2025 /PRNewswire/ -- ACES India, a fully owned subsidiary of ACES (Saudi Arabia), has partnered with…
New York City, NY, Oct. 11, 2025 (GLOBE NEWSWIRE) -- Introduction In 2025, artificial intelligence continues to revolutionize the financial…
RIYADH, Saudi Arabia, Oct. 9, 2025 /PRNewswire/ -- Saudi Arabia's industrial sector is entering a new era of transformation, driven…
SHENZHEN, China, Oct. 05, 2025 (GLOBE NEWSWIRE) -- XPPen, a global leader in digital art innovation, unveils its Prime Big…
Bravent’s Miami gathering advanced collaboration around innovation driven by Artificial Intelligence, reinforcing South Florida’s hub of innovation through corporate and university…
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data 50 mg once-daily dose of obefazimod led…
Image by Contemporary Care NAPLES, Fla., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Contemporary Care today announced the availability of Transcranial…